Protecting Patients & Stabilizing Markets: The Role of Standards in a Fragmented Cannabis Landscape

As cannabis markets continue to expand absent federal alignment, fragmentation between states continues to create unintended consequences, particularly for patients. What regulators and operators often see as compliance challenges, medical providers, patients, and consumers alike experience as safety and consistency gaps. In this candid and engaging discussion, you will hear frontline insights from a leading health care professional around emerging concerns spanning synthetic cannabinoids, product differentiation, and the erosion of meaningful medical safeguards. We’ll also be joined by a former head regulator to understand why many of these challenges persist, how states have navigated them in the absence of federal frameworks, and where harmonized standards can provide practical, scalable solutions. Together, we will explore how S3 Collective convenes clinical, scientific, and regulatory expertise to translate research into market-relevant standards, ultimately equipping states with credible tools to protect patients while supporting responsible industry growth. Attendees will: -Understand key patient safety and consistency challenges emerging in today’s cannabis marketplace -Gain insight into why regulatory fragmentation persists across states -Examine the tension between medical and adult-use frameworks, and its impact on safeguards -Explore how consensus standards can support harmonization without federal mandates -Identify opportunities to engage in advancing credible, patient-centered standards This conversation is part of S3 Collective’s ongoing educational webinar series on medical cannabis.